EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dioscin ameliorates doxorubicin‐induced heart failure via inhibiting autophagy and apoptosis by controlling the PDK1 ‐mediated Akt/ mTOR signaling pathway

Ling Yuan, Hai-Gang Ji, Xiao-Jing Yan, Meng Liu, Yu-Han Ding, Xiao-Hu Chen iD

The Kaohsiung Journal of Medical Sciences · 2023-10 · 39 (10) · 1022-1029

DOI: 10.1002/kjm2.12740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, online erschienen am 14.08.2023. Verfasst von Ling Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is a disease with high mortality and morbidity rate. Autophagy is critically implicated in HF progression. The current research was designed to investigate the function of Dioscin on oxidative stress, autophagy, and apoptosis in HF. In this study, doxorubicin (Dox) was employed to induce HF model and HL‐1 cell damage model. Echocardiography implied that Dioscin could dramatically relieve heart function in vivo. Western blotting determined that Dioscin treatment reversed the promotive effect of autophagy caused by Dox through modulating levels of key autophagy‐associated molecules, including Atg5 and Beclin1. Dioscin also impaired apoptosis by regulating apoptosis‐related protein, including Bcl‐2 and cleaved caspase‐3 following Dox treatment in vivo and in vitro. Furthermore, the impacts of Dioscin were mediated by upregulation of PDK1‐mediated Akt/mTOR signaling. The mTOR inhibitor (rapamycin) could counteract the therapeutic impact of Dioscin in vitro. Taken together, Dioscin could relieve cardiac function through blocking apoptosis and autophagy by activating the PDK1‐elicited Akt/mTOR pathway.

Schlagwörter

Stichwörter der Autor:innen

Akt/mTORDioscinPDK1doxorubicinheart failure

Autor:innen und Institutionen

  • Department of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
  • Department of Cardiology, Changzhou Hospital Affiliated to Nanjing University of Chinese Medicine, Changzhou, China.
  • Changzhou Key Laboratory of Human Use Experience Research & Transformation of Menghe Medical School, Changzhou Hospital Affiliated to Nanjing University of Chinese Medicine, Changzhou, China.

ORCID-Profile: Xiao-Hu Chen

Zitieren

APA

Yuan, L., Ji, H. G., Yan, X. J., Liu, M., Ding, Y. H., & Chen, X. H. (2023). Dioscin ameliorates doxorubicin‐induced heart failure via inhibiting autophagy and apoptosis by controlling the PDK1 ‐mediated Akt/ mTOR signaling pathway. The Kaohsiung Journal of Medical Sciences, 39(10), 1022-1029. https://doi.org/10.1002/kjm2.12740

Vancouver

Yuan L, Ji HG, Yan XJ, Liu M, Ding YH, Chen XH. Dioscin ameliorates doxorubicin‐induced heart failure via inhibiting autophagy and apoptosis by controlling the PDK1 ‐mediated Akt/ mTOR signaling pathway. The Kaohsiung Journal of Medical Sciences. 2023;39(10):1022-1029. doi:10.1002/kjm2.12740

BibTeX
@article{Yuan2023,
  author = {Yuan, Ling and Ji, Hai-Gang and Yan, Xiao-Jing and Liu, Meng and Ding, Yu-Han and Chen, Xiao-Hu},
  title = {Dioscin ameliorates doxorubicin‐induced heart failure via inhibiting autophagy and apoptosis by controlling the PDK1 ‐mediated Akt/ mTOR signaling pathway},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2023},
  volume = {39},
  number = {10},
  pages = {1022--1029},
  doi = {10.1002/kjm2.12740}
}
Kostenlos starten →